Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001451980-10-000004
Filing Date
2010-03-18
Accepted
2010-03-18 14:59:08
Documents
6
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 10-K FILING - 2009 filing10k.htm 10-K 2268997
2 EXHIBIT 31.1 exhibit311.htm EX-31.1 12616
3 EXHIBIT 31.2 exhibit312.htm EX-31.2 12946
4 EXHIBIT 32.1 exhibit321.htm EX-32.1 8976
5 EXHIBIT 32.2 exhibit322.htm EX-32.2 8933
6 GRAPHIC IMAGE filing10k1.jpg GRAPHIC 29587
  Complete submission text file 0001451980-10-000004.txt   2354920
Mailing Address BECK SCIENCE CENTER 8 HARTOM STREET, HAR HOTZVIM JERUSALEM L3 97775
Business Address BECK SCIENCE CENTER 8 HARTOM STREET, HAR HOTZVIM JERUSALEM L3 97775 972-2-548-6555
BIOCANCELL THERAPEUTICS INC. (Filer) CIK: 0001451980 (see all company filings)

EIN.: 204630076
Type: 10-K | Act: 34 | File No.: 000-53708 | Film No.: 10691351
SIC: 2834 Pharmaceutical Preparations